ArticleCancer discovery2022
Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLC.
Kwan Ho Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
72 papers cite itlatest 60 shown
this papercites it
ArticleCancer discovery2022
Kwan Ho Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.